DexCom has a better P/E ratio of 65.84 than the aggregate P/E ratio of 53.6 of the Health Care Equipment & Supplies industry. Ideally, one might believe that DexCom Inc. might perform better in the ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Retail chatter surged for Abbott and Dexcom on Tuesday after U.S. Health Secretary Robert F. Kennedy Jr. announced a sweeping ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

Shares of DexCom Inc. DXCM slipped 1.00% to $81.01 Wednesday, on what proved to be an all-around rough trading session for ...

Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports ...

DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and ...

Dexcom is working to replace some of the receivers that link with its continuous glucose monitoring systems due to a ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.38, a high estimate of $106.00, and a low estimate of $85.00. Surpassing the previous average price ...